Literature DB >> 23850293

Prognostic value of fragmented QRS on a 12-lead ECG in patients with acute myocardial infarction.

Luc Lorgis1, François Jourda, Olivier Hachet, Marianne Zeller, Aurelie Gudjoncik, Gilles Dentan, Karim Stamboul, Charles Guenancia, Laurent Mock, Yves Cottin.   

Abstract

OBJECTIVE: To investigate the determinants and the prognostic value of fragmented QRS (fQRS) after AMI. PATIENTS AND METHODS: Prospective cohort of 307 consecutive patients with AMI. MAIN OUTCOMES MEASURED: MACE (death plus non-fatal recurrent MI), hospitalization for an episode of heart failure, ventricular arrhythmia (VT or VF) at two years follow-up.
RESULTS: On the serial 12-lead ECG recorded during the in-hospital stay, 162 (53%) had no fQRS (no fQRS group). 145 (47%) presented an fQRS, which was persistent in 108 (34%) patients (persistent fQRS group) and transient in 37 (12%) patients (transient fQRS group). Patients with a fragmented QRS (transient or persistent) were older, more likely to be hypertensive and less likely to be smokers than were patients without fQRS. By multivariate logistic regression analysis, only hypertension (OR (95% CI): 1.66 (1.00-2.74); p = 0.047) was associated with an fQRS. During a mean follow-up of 846 ± 297 days, there were 82 MACE recorded: 17 patients died from a CV cause (10% event rate) among patients without fQRS, 22 (20% event rate) among patients with persistent fQRS and 3 (8% event rate) among patients with transient fQRS. Similarly, non-fatal recurrent MI occurred more frequently in patients with fQRS (18 (16%) and 10 (27%)) for persistent and transient fQRS, respectively, vs. 16 (10%) in the no fQRS group (p = 0.019). However, the occurrence of heart failure symptoms and ventricular arrhythmia was not significantly different (p = 0.162 and p = 0.242, respectively). Survival analysis by the Kaplan-Meier method showed a significant difference (log rank p = 0.026) between groups, and only persistent fQRS was associated with decreased survival. In multivariate cox regression analysis, the GRACE score, blood glucose on admission, and B-blockers in the acute phase were independent predictors of MACE at two years. fQRS was not a significant independent predictor of MACE (HR (95% CI): 1.57 (0.95-2.60); p = 0.08). Moreover, fQRS was not a predictor of heart failure or ventricular arrhythmia in univariate analysis.
CONCLUSIONS: Persistent fQRS on a 12-lead ECG is a marker of decreased survival after AMI, whereas transient fQRS correlates with recurrent MI. Crown
Copyright © 2013. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  AMI; CAD; ECG; FQRS; Fragmented QRS; LVEF; Myocardial infarction; NON-ST segment elevation myocardial infarction; NON-STEMI; Prognosis; ST-segment elevation myocardial infarction; STEMI; acute myocardial infarction; coronary artery disease; electrocardiogram; fragmented QRS; left ventricular ejection fraction

Mesh:

Year:  2013        PMID: 23850293     DOI: 10.1016/j.hrtlng.2013.05.005

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  21 in total

Review 1.  Total Mortality, Major Adverse Cardiac Events, and Echocardiographic-Derived Cardiac Parameters with Fragmented QRS Complex.

Authors:  Bojun Gong; Zicheng Li
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-11-02       Impact factor: 1.468

2.  Temporal trend might be better than instant occurrence of fQRS as a noninvasive prognostic marker in STEMI patients undergoing primary PCI.

Authors:  Uğur Canpolat; Dursun Aras; Serkan Topaloğlu; Sinan Aydoğdu
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-11       Impact factor: 1.468

3.  When should fQRS be evaluated as a noninvasive prognostic marker in patients undergoing primary PCI with STEMI?

Authors:  Mehmet Gul; Nevzat Uslu; Hulusi Satılmısoglu; Sinem Ozbay Ozyılmaz
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-13       Impact factor: 1.468

4.  The assessment of relationship between fragmented QRS complex and left ventricular wall motion score index in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention.

Authors:  Nevzat Uslu; Mehmet Gul; Huseyin Altug Cakmak; Ali Atam; Hamdi Pusuroglu; Hulusi Satilmisoglu; Emre Akkaya; Hale Unal Aksu; Ali Kemal Kalkan; Ozgur Surgit; Mehmet Erturk; Huseyin Aksu; Abdurrahman Eksik
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07-17       Impact factor: 1.468

5.  Prognostic Value of QRS Fragmentation in Patients with Acute Myocardial Infarction: A Meta-Analysis.

Authors:  Barış Güngör; Kazım Serhan Özcan; Mehmet Baran Karataş; İrfan Şahin; Recep Öztürk; Osman Bolca
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-28       Impact factor: 1.468

6.  Significance of fragmented QRS complexes for identifying left ventricular hypertrophy in patients with hypertension.

Authors:  Baowei Zhang; Ya Zhen; Dongli Shen; Guohui Zhang
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-09-18       Impact factor: 1.468

Review 7.  The role of fQRS in coronary artery disease. A meta-analysis of observational studies.

Authors:  Y Xu; Z Qiu; Y Xu; H Bao; S Gao; X Cheng
Journal:  Herz       Date:  2014-10-23       Impact factor: 1.443

8.  Fragmented QRS on surface electrocardiogram is not a reliable predictor of myocardial scar, angiographic coronary disease or long term adverse outcomes.

Authors:  Dee Dee Wang; Amit Tibrewala; Phuc Nguygen; Tanmay Swadia; Gordon Jacobsen; Arfaat Khan; Karthik Ananthasubramaniam
Journal:  Cardiovasc Diagn Ther       Date:  2014-08

9.  Fragmented QRS as a predictor of in-hospital life-threatening arrhythmic complications in ST-elevation myocardial infarction patients.

Authors:  Tanawat Attachaipanich; Rungroj Krittayaphong
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-08-17       Impact factor: 1.468

10.  [Fragmented QRS. Relevance in clinical practice].

Authors:  Alexander Steger; Daniel Sinnecker; Anna Berkefeld; Alexander Müller; Josef Gebhardt; Michael Dommasch; Katharina M Huster; Petra Barthel; Georg Schmidt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.